Reported Standalone quarterly numbers for Ishita Drugs and Industries are: Net Sales at Rs 3.21 crore in December 2023 down 1.43% from Rs. 3.26 crore in December 2022. Quarterly Net Profit at Rs. 0.12 crore in December 2023 up 3.58% from Rs. 0.12 crore in December 2022. EBITDA stands at Rs. 0.23 crore in December 2023 up 27.78% from Rs. 0.18 crore in December 2022.

Reported Standalone quarterly numbers for Coral Laboratories are: Net Sales at Rs 18.08 crore in December 2023 down 26.89% from Rs. 24.73 crore in December 2022. Quarterly Net Profit at Rs. 2.16 crore in December 2023 up 151.45% from Rs. 0.86 crore in December 2022. EBITDA stands at Rs. 3.54 crore in December 2023 up 50.64% from Rs. 2.35 crore in December 2022.

Reported Standalone quarterly numbers for Ipca Laboratories are: Net Sales at Rs 1,506.83 crore in December 2023 up 5.17% from Rs. 1,432.79 crore in December 2022. Quarterly Net Profit at Rs. 136.94 crore in December 2023 up 13.86% from Rs. 120.27 crore in December 2022. EBITDA stands at Rs. 290.38 crore in December 2023 up 21.35% from Rs. 239.29 crore in December 2022.

Smallcap stocks have been on a rapid rise, creating a valuation hangover for investors. The Nifty SmallCap 100 index is trading at its highest P/B value since FY13 and 128 smallcap multibaggers are trading above their 5-year average PE level. This trend is seen across various sectors, with the index currently at 149% of its historical valuation.

Reported Standalone quarterly numbers for Aarey Drugs and Pharmaceuticals are: Net Sales at Rs 76.48 crore in December 2023 up 22.42% from Rs. 62.47 crore in December 2022. Quarterly Net Profit at Rs. 1.02 crore in December 2023 up 106.73% from Rs. 0.49 crore in December 2022. EBITDA stands at Rs. 2.99 crore in December 2023 up 48.76% from Rs. 2.01 crore in December 2022.

Real estate company CBRE Group Inc expects strong annual profits, driven by demand for leasing and loan servicing services despite a sluggish commercial property market due to higher interest rates. With a full-year earnings per share forecast above analysts' expectations, the company's stock rose 6.5% in premarket trade. While property sales have declined, leasing revenues in Europe saw growth.

Singapore's state investment firm Temasek has sold 1.1 percent stake in Indian hospital chain Medanta for S$64 million, generating a realised internal rate of return of about 26 percent over nine years. This partial exit will put the multiple on invested capital at eight times and Temasek retains a stake of about 17 percent in Medanta.

The State Bank of India is asking the Reserve Bank of India to reduce the cash reserve ratio requirement for green deposits raised by banks. SBI recently launched a green fixed deposit scheme and is evaluating borrowers based on their ESG rating. The regulator has taken steps to encourage green deposits, but it may take a few years for it to have an impact on pricing.

Nvidia is now the 3rd most valuable US company due to its soaring stock price, reaching $1.8 trillion in mcap. This rise was fueled by high demand for its AI chips, with over 80% of the high-end market share. Analysts predict continued growth and advise caution due to potential risks and high valuations. Indian investors can access US stocks through domestic or foreign brokers or mutual funds.

Reported Standalone quarterly numbers for Edvenswa Enterprises are: Net Sales at Rs 0.45 crore in December 2023 up 4.71% from Rs. 0.43 crore in December 2022. Quarterly Net Profit at Rs. 0.11 crore in December 2023 up 96.9% from Rs. 0.05 crore in December 2022. EBITDA stands at Rs. 0.15 crore in December 2023 down 0% from Rs. 0.15 crore in December 2022.

IMP Powers reported standalone quarterly numbers for December 2023, with a net sales of Rs. 0.35 crore, down 96% from the previous year. The company also recorded a quarterly net loss of Rs. 3.25 crore, showing a decrease of 2.05% from the same quarter in 2022. EBITDA stood negative at Rs. 1.71 crore, down 8.92% from December 2022.

Glenmark Pharma stock continues to rise, with a 10% surge on Feb 16. Q3 earnings were impacted by one-time expenses, but management expects improvement in EBITDA and margins, driven by new production site and upcoming product launches. Glenmark aims to turn cash positive and expects significant sales from its nasal spray Ryaltris.

KPI Green Energy's shares surged 5% after its subsidiary received a new order for a 1.5 MW solar power project, expected to be completed by FY 2024-25. The stock has delivered multibagger returns in the past six months and three years. In the December quarter, the company reported a 47% rise in net profit and a significant increase in revenue. It is currently trading above its SMAs.

Reported Standalone quarterly numbers for Jeevan Scientific Technology are: Net Sales at Rs 10.13 crore in December 2023 up 1.77% from Rs. 9.95 crore in December 2022. Quarterly Net Loss at Rs. 0.39 crore in December 2023 down 822.02% from Rs. 0.05 crore in December 2022. EBITDA stands at Rs. 0.98 crore in December 2023 down 43.68% from Rs. 1.74 crore in December 2022.

After a flat January, Indian markets have surged almost 1.5% in the month of February. Both Nifty Finance and Nifty FMCG underperformed the benchmark Nifty in the last 1 year. Nifty FMCG jumped over 16% while Nifty Fin gained 9.5% as against a 21.6% rise in the Nifty in the last 1 year. Deepak Jasani, Head of Retail Research, HDFC Securities likes Nifty Finance over Nifty FMCG.